rss
Postgrad Med J 2004;80:247
  • LETTER

Drug therapy in chronic heart failure

  1. O Jolobe
  1. Manchester, UK; oscarjolobeyahoo.co.uk

      In their recent paper on drug therapy in chronic heart failure the authors addressed all the important issues.1 Blood volume depletion (mediated by drug related augmentation of diuresis) complicates “triple therapy” when spironolactone is co-prescribed with loop diuretics and angiotensin converting enzyme inhibitors.2–4 Therefore, over and above the recommendation to check renal function and potassium levels, I would add that patients on triple therapy should have strict monitoring of their daily weight so as to pre-empt prerenal uraemia by appropriate titration of diuretic dosage.

      References

      Register for free content


      Free sample
      This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of PMJ.
      View free sample issue >>

      Free archive
      The full back archive is now available for PMJ. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.